Review ArticleInternational Journal of Pharmaceutical InvestigationVol. 5 | Issue 1 | pp. 13–19Open access
Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
- 1,
- 2*
- 1 Departments of Pharmaceutics.
- 2 Drug Regulatory Affairs, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Divya Sadhna
Drug Regulatory Affairs, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, INDIA.
Email: divya_pharmrx@yahoo.co.in
- DOI:
- 10.4103/2230-973X.147222
How to cite
Nagaich, U., & Sadhna, D. Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history. International Journal of Pharmaceutical Investigation, 5(1), 13–19. https://doi.org/10.4103/2230-973X.147222
Abstract
There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company’s discovery, customer’s complaint or Food and Drug Administration (FDA) observation. The process of recall involves a planned specific course of action, which addresses the depth of recall, need for public warning, and the extent of effectiveness checks for the recall. The FDA review and/or recommend changes to the firm’s recall strategy, as appropriate. The critical recall information list includes the identity of the product; summary of the failure; amount of product produced in the distribution chain and direct account. Product recalls clashes thousands of companies every year affecting: sales, testing customer relationships and disrupting supply chains. Drug recall is incubus for pharmaceutical companies. It effects the reputation of the company. The reason for the recall can be divided into two categories: manufacturing affined and safety/efficacy affined. It is essential to follow all the guidelines related to drug development and manufacturing procedure so as to minimize drug recall.
Keywords
Subject
Article metadata
| Title | Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history |
|---|---|
| Authors | Upendra Nagaich; Divya Sadhna |
| Affiliations | Departments of Pharmaceutics.; Drug Regulatory Affairs, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, INDIA. |
| Corresponding author | divya_pharmrx@yahoo.co.in |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 5, Issue 1 |
Also in this issue
- Role of excipients and polymeric advancements in preparation of floating drug delivery systemspp. 1–12
- Statistical modeling of zaltoprofen loaded biopolymeric nanoparticles: Characterization and anti-inflammatory activity of nanoparticles loaded gelpp. 20–27
- Liposomal Aloe vera trans-emulgel drug delivery of naproxen and nimesulide: A studypp. 28–34
- Evaluation of the efficacy of 2% Ocimum sanctum gel in the treatment of experimental periodontitispp. 35–42
- Colon specific drug delivery of tramadol HCl for chronotherapeutics of arthritispp. 43–49